Latest MS research news

Latest MS research news | 04 June 2013

Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients

This retrospective study looked at the efficacy and safety of mycophenolate mofetil (MMF), which is commonly used after organ transplantation to prevent graft rejection. The researchers found a positive effect of MMF on MS relapse and the treatment was quite well tolerated overall.

From MSIF

Latest MS research news | 28 May 2013

Predictive value of one month retinal nerve fiber layer thinning for deficits at six months after acute optic neuritis

The retinal nerve fibre layer (RNFL) was assessed in people with acute optic neuritis. The study group found a correlation between RNFL at 1 month and 6 months, suggesting that by 1 month, permanent injury has already occurred in the affected eyes.

From MSIF

Latest MS research news | 28 May 2013

T-cell response against varicella-zoster virus in people with MS treated with fingolimod

This study looked at the immune response against varicella-zoster virus (which causes chicken pox and shingles) and Epstein-Barr virus (which causes glandular fever) and found that a specific part of the immune response was reduced in people treated with fingolimod.

From MSIF

Latest MS research news | 28 May 2013

The effect of vitamin D-related interventions on MS relapses: a meta-analysis

This research group looked at five recently published studies to examine the effect of vitamin D supplementation on the relative risk of relapse in MS and found no association.

From MSIF

Latest MS research news | 21 May 2013

Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease

The researchers in this study looked at a specific imaging biomarker of spinal cord tissue injury called diffusion tensor imaging (DTI). This gives us an insight into the tract-specific substrates of physical impairment in MS and neuromyelitis optica (NMO).

From MSIF

Latest MS research news | 21 May 2013

Brain reserve and cognitive reserve in MS: What you've got and how you use it.

The results from this Italian study demonstrate that early life intellectual enrichment (cognitive reserve) protects people with MS from disease-related cognitive impairment independently of brain reserve.

From MSIF

Latest MS research news | 21 May 2013

Lifestyle profile of people at the time of their first clinical demyelinating event: results from Ausimmune study

This study compares the lifestyle profile of people presenting with their first clinical demyelinating event.

From MSIF

Latest MS research news | 14 May 2013

The effects of long-term interferon- beta-1b treatment on cognitive functioning in MS: a 16-year longitudinal study.

This study evaluated the long term changes in cognitive function in MS patients treated with IFN-β-1b and it provides support for the importance of early intervention in treatment.

From MSIF

Latest MS research news | 14 May 2013

Clinical impact of early brain atrophy in clinically isolated syndromes

The results from this study showed that during the first year after a clinically isolated syndrome, patients who develop a second attack during the follow up period have larger brain volume losses than those who do not.

From MSIF

Latest MS research news | 14 May 2013

Assessing the validity of a computer-generated cognitive screening instrument for people with MS

This study looked at a computer generated battery of memory tests which looked at a number of different cognitive domains including information processing speed and executive function.

From MSIF
 

Latest MS research news

Main MS research areas

Challenges of MS research

Atacicept in multiple sclerosis: a randomised, placebo-controlled, double-blind, phase 2 trial